Description

(4R)-4-[(3S,5S,7S,8S,9S,10R,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is a high-purity steroidal compound of significant interest in advanced pharmaceutical research and development. This molecule serves as a critical intermediate or reference standard for synthesizing and analyzing complex bioactive molecules. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers working on steroid-based therapeutics and diagnostic agents.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel steroid-based drugs targeting hormonal regulation and metabolic pathways.
• Reference Standard: Used for analytical method development, validation, and quality control (QC) in pharmaceutical manufacturing to ensure product purity and consistency.
• Biochemical Research: Employed in academic and industrial research to study steroid receptor interactions, enzyme inhibition, and metabolic processes.
• Active Pharmaceutical Ingredient (API) Development: Serves as a precursor in the development of new steroidal active ingredients for various therapeutic applications.
• Diagnostic Reagent Manufacturing: Utilized in the production of reagents and kits for clinical diagnostics related to steroid hormone levels.

Basic Information

Product Name	(4R)-4-[(3S,5S,7S,8S,9S,10R,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
CAS No.	78919-26-3
Molecular Formula	C24H38O4
Molecular Weight	390.56 g/mol
Synonyms	3,7-Dihydroxy-5-cholestenoic acid; 3,7-Dihydroxy-5-cholenoic acid; 3α,7α-Dihydroxy-5-cholestenoic acid; 3α,7α-Dihydroxy-5β-cholestenoic acid; 5-Cholestene-3α,7α-diol-26-oic acid; (25R)-3α,7α-Dihydroxy-5-cholestenoic acid; 27-Nor-5-cholestene-3α,7α,26-triol
EINECS	Contact for details

Quality Control

Our (4R)-4-[(3S,5S,7S,8S,9S,10R,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC and spectroscopic methods, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific GMP or research-grade requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which can affect stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.